ImClone Systems | Evaluate

October 26, 2016

Buy or build – big pharma’s freshness dilemma

February 24, 2016

The US FDA shows its teeth

October 13, 2015

One deal rules them all in the third quarter

October 13, 2015

Another fail for Lilly’s labs – time to make a deal?

June 19, 2014

For oncology deals, don’t forget the other Merck

April 25, 2014

Celgene’s record-breaking deal hangs on phase II data

August 14, 2013

ImClone gives Lilly its second pivotal trial surprise

January 23, 2013

In Regard to ramu, filing looks unlikely until Rainbow’s end

October 16, 2012

Lilly’s ramucirumab comes off the bench with a clutch single

May 14, 2012

EP Vantage Interview - F-Star to push forward with bispecific antibody pipeline

March 21, 2012

Therapeutic focus - Votrient a blazing trail in soft tissue sarcoma

Load More